Page last updated: 2024-08-25

clarithromycin and Colorectal Cancer

clarithromycin has been researched along with Colorectal Cancer in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Arcangeli, A; Bagni, G; Becchetti, A; Duranti, C; Iorio, J; Kragol, G; Lottini, T; Petroni, G; Stefanini, M1
Doki, Y; Eguchi, H; Hayashi, N; Kagawa, Y; Komori, T; Matsuda, C; Mizushima, T; Morita, S; Murata, K; Nakata, K; Noura, S; Ota, H; Saso, K; Satoh, T; Uemura, M1
Makihara, K; Miyagi, K; Nakamura, S; Nakata, I; Ueno, H1
Donadoni, G; Ferreri, AJ; Govi, S; Kiesewetter, B; Raderer, M; Sassone, M; Scarfò, L1
Akazawa, Y; Ichikawa, T; Isomoto, H; Matsushima, K; Nakao, K; Ohnita, K; Senoo, T; Shiozawa, K; Takeshima, F; Yamaguchi, N1

Trials

2 trial(s) available for clarithromycin and Colorectal Cancer

ArticleYear
Pre-emptive oral clarithromycin reduces the skin toxicity of panitumumab treatment for metastatic colorectal cancer.
    International journal of colorectal disease, 2021, Volume: 36, Issue:12

    Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Colorectal Neoplasms; Humans; Panitumumab

2021
High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:8

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Breast Neoplasms; Clarithromycin; Colorectal Neoplasms; Disease-Free Survival; Eye Neoplasms; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Mouth Neoplasms; Neoplasms, Multiple Primary; Salvage Therapy; Skin Neoplasms; Stomach Neoplasms

2015

Other Studies

3 other study(ies) available for clarithromycin and Colorectal Cancer

ArticleYear
Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K.
    Cell death & disease, 2020, 03-02, Volume: 11, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Autophagosomes; Autophagy; Cell Line, Tumor; Cell Survival; Clarithromycin; Colonic Neoplasms; Colorectal Neoplasms; Ether-A-Go-Go Potassium Channels; Humans; Phosphatidylinositol 3-Kinases; Signal Transduction

2020
Clarithromycin co-administration does not increase irinotecan (CPT-11) toxicity in colorectal cancer patients.
    Cancer chemotherapy and pharmacology, 2017, Volume: 80, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Clarithromycin; Colorectal Neoplasms; Female; Humans; Irinotecan; Male; Middle Aged; Retrospective Studies

2017
Successful management of cap polyposis with eradication of Helicobacter pylori relapsing 15 years after remission on steroid therapy.
    Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Colorectal Neoplasms; Endoscopy, Digestive System; Female; Glucocorticoids; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Polyposis; Prednisolone; Rabeprazole; Recurrence; Remission Induction

2012